Recently, astrocyte-derived VEGFA was reported to drive blood-brain barrier disruption (where astrocytes also retract their endfeet from vessels) in brain inflammatory disease and inhibition of VEGFA signaling suggested as a protective approach (Argaw et al., 2012). Here, VEGFA is linked to brain inflammatory disease.